معرفی
Samuel Vidal, M.D., Ph.D., serves as an Instructor in Medicine at Harvard Medical School, an infectious diseases physician at Brigham and Women’s Hospital, and a Staff Scientist in the Barouch laboratory at the Center for Virology and Vaccine Research. His clinical responsibilities encompass inpatient and outpatient infectious diseases services at Brigham and Women’s Hospital, integrating direct patient care with translational research.
Dr. Vidal's educational journey includes:
- B.A. in Biochemistry from Haverford College
- Concurrent M.D. and Ph.D. degrees from Columbia University's Medical Scientist Training Program
- Internal Medicine internship and residency at New York Presbyterian Hospital Columbia campus
- Infectious Diseases subspecialty training at Massachusetts General Hospital and Brigham and Women’s Hospital
- NIH T32 postdoctoral research fellowship in the Barouch laboratory
His research program centers on pioneering antigen-based and live-attenuated tuberculosis vaccines, operating at the critical intersection of virology, immunology, and infectious disease pathogenesis. This work leverages the Barouch laboratory's expertise in viral vector platforms to address global tuberculosis challenges through novel vaccine design and efficacy evaluation.
As leader of the tuberculosis vaccine development team within the Center for Virology and Vaccine Research, Dr. Vidal mentors junior scientists and coordinates preclinical research activities. While specific grant mechanisms aren't detailed, his NIH T32 fellowship background suggests strong federal research training foundations.
The Barouch laboratory provides the primary research ecosystem for Dr. Vidal's work, situated within Harvard Medical School's Department of Medicine and affiliated with Brigham and Women’s Hospital. This environment enables direct translation of vaccine discoveries from bench to clinical application through hospital-based infectious diseases expertise.
